Frontlight ResearchEarly access
Trial site
Indiana University Simon Comprehensive Cancer Center
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Burkitt lymphoma1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Acepodia Biotech, Inc.1 trial
- Angiocrine Bioscience1 trial
- Genelux Corporation1 trial
- Indiana University1 trial
- NiKang Therapeutics, Inc.1 trial
- and 3 more
Running trials
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Active, not recruiting
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026